S&P revises UAB Medicine’s outlook to negative over weaker operations

S&P Global Ratings revised Birmingham, Ala.-based UAB Medicine’s outlook to negative from stable.

Advertisement

S&P also affirmed its “AA-” long term rating on the health system’s revenue bonds.

The outlook revision is a result of UAB Medicine’s weaker operating margins in the last two fiscal years, which resulted in a lowered annual debt service coverage. The new maximum annual debt service coverage is not in line with its current “AA-” long-term rating.

More articles on healthcare finance:
TransUnion Healthcare keeping contract with VA 
41 hospital, health system outlook and credit rating actions in July
Proposed physician fee changes credit negative for academic med centers, some rural hospitals, Moody’s says

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.